AstraZeneca PLC

AZN: XLON (GBR)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|&KfLOCK|^$TLOCK|s<rv>?^

AstraZeneca's Portfolio and Pipeline Support Solid Long-Term Growth

Business Strategy and Outlook

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets up solid long-term growth.

Sponsor Center